MTOR and fatty liver disease: Using the previous fatty liver model, it was further revealed that HFD induction in KO control mice led to mTOR signaling pathway activation in the liver, as evidenced by increased levels of p-mTOR, GβL, p-p70S6, and p-4EBP-1 (Fig. 4C-D).